Screener
Cytokinetics CYTK AOCI
AOCI at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
FAQ
- What is Cytokinetics's AOCI?
- Cytokinetics (CYTK) reported AOCI of -$3.83M in Q2 2026.
- How has Cytokinetics's AOCI changed year-over-year?
- Cytokinetics's AOCI decreased by 2321.5% year-over-year, from -$158K to -$3.83M.
- What is the long-term trend for Cytokinetics's AOCI?
- Over 5 years (2020 to 2025), Cytokinetics's AOCI has grown at a 33.4% compound annual growth rate (CAGR), from $149K to $630K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.
Ask your AI about Cytokinetics's aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude